ENVISION data inform the use of chemoablation in recurrent LG-IR-NMIBC - Urology Times
ENVISION data inform the use of chemoablation in recurrent LG-IR-NMIBC Urology Times
ENVISION data inform the use of chemoablation in recurrent LG-IR-NMIBC Urology Times
Urine test may improve bladder cancer diagnosis and guide treatment decisions Stanford Medicine
10 Must-Read Posts In GU Oncology This Week Oncodaily
Chiral Cerium Nanoreactors Light the Way to Sharper Bladder Cancer Surgery and Therapy Bioengineer.org
Markey physician leads new international guidance on bladder cancer biomarkers UKNow
Bladder cancer mistaken for UTI, perimenopause in women ABC News & Headlines – Australian Broadcasting Corporation
SPIN Study Explores Pelvic Floor Care for Women With Bladder Cancer University of Miami
A New Approach to Preventing Bladder Cancer Recurrence News-Medical
Stanford Researchers Develop RNA-Based Urine Test to Detect Bladder Cancer, Determine Treatment Response Genome Web
Smoking and bladder cancer: What to know Medical News Today
Longtime TV anchor leaving morning show amid bladder cancer treatment SILive.com
Research Roundup: Nobel Prize for neuroscience, smarter bladder cancer test The Stanford Daily
New ASTRO Guidelines Focus on Radiation for Bladder Cancer Medscape
3 reasons why an accurate bladder cancer diagnosis matters UT MD Anderson
ASTRO Issues Its First Clinical Guideline on Radiation Therapy for Bladder Cancer The ASCO Post
New Combination Therapy Shows Promise for Advanced Bladder Cancer University of Colorado Anschutz
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms Memorial Sloan Kettering Cancer Center
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery Mayo Clinic News Network
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer NEJM
Tom Powles: ESMO26 Examines Three Randomized Trials in Muscle-Invasive Bladder Cancer Oncodaily
Bladder Cancer: What You Need to Know to Detect It Early Dana-Farber Cancer Institute
Xpert bladder cancer detection and monitor in urothelial carcinoma: systematic review and meta-analysis Nature
Key Bladder Cancer Trials to Watch in 2026 Oncology News Central
A new sensor could enable earlier detection of bladder cancer MIT News
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer ASCO Publications
How Long Should EV-Pembrolizumab Continue in Advanced Bladder Cancer? Oncology News Central
Immune Biomarkers May Predict Response to Bladder Cancer Treatment Northwestern University
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy UT MD Anderson
Beyond the diagnosis: What living with bladder cancer really looks like Johnson & Johnson
Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer CancerNetwork
Surgeons now using ‘pretzels’ to spare bladder for noninvasive bladder cancer patients Vanderbilt Health News
Vitamin D Gene Variants Fail to Explain Bladder Cancer Risk in Turkish Study Bioengineer.org
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
Cretostimogene Grenadenorepvec in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer The ASCO Post
New study looks at pesticide exposure and bladder cancer risk among Hmong farmworkers UC Davis Health
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing CancerNetwork
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches UroToday
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ASCO Publications
The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options Cure Today